CX3CR1 siRNA (m) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) CX3CL1 deficiency ameliorates acute kidney injury by inhibiting macrophage mitochondrial dysfunction and mtDNA-cGAS-STING signalingCell Death DiscoveryDecember 13, 2025Qiming Gong, Fahui Liu, Yuqing Huang, Dehui Li, Tingting Zhou, Chen Zeng, Yan Jiang, Huang Wei, Yong Xuwere used. TFAM siRNA (cat. no. SC-45912; Santa Cruz Biotechnology, Inc.) and CX3CR1 siRNA (cat. no. sc-39905; Santa Cruz Biotechnology, Inc.) were used to transfect cells. To simulate the AKI inflammatory environment

(3) Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signalingJournal of NeuroinflammationJanuary 22, 2014Teresita L Briones, Julie Woods, Magdalena Wadowskaconsideration the predictable ventricular shifts after ischemic injury [21]. CX3CR1 siRNA (product # sc-39905) and scrambled RNA (control; product # sc-37007) were designed and synthesized by Santa Cruz Biotechnology

(4) Suppressed pro-inflammatory response of microglia in CX3CR1 knockout miceJournal of neuroimmunologyApril 15, 2013Mattison HA, Nie H, Gao H, Zhou H, Hong JS, Zhang J.

CX3CR1 siRNA (m)